NCT04988204View on ClinicalTrials.gov

Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 3, 2018

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Nonalcoholic Fatty Liver Disease
Interventions
BEHAVIORAL

Diabetes Prevention Program

The Diabetes Prevention Program is a 1 year validated program to prevent the development of type 2 diabetes. Participants with NAFLD will engage will work with a CDC certified DPP certified lifestyle coach and other participants in a group setting during the study focusing on lifestyle changes to achieve weight loss and improvement in NAFLD.

Trial Locations (1)

10003

Mount Sinai Union Square, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT04988204 - Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter